Overall Technical outlook

Price Summary

Sun Pharmaceutical Industries Limited's stock saw a 2.11% rise, showcasing an remarkable market day.
On 2026-04-30, Sun Pharmaceutical Industries Limited's stock began at 1771.0, climbed to 1815.0, dropped to 1761.4, and had 2.11% to end at 1808.3, with a volume of 4749696 shares.
The stock reached its highest price of 1836.6 and lowest price of 1563.3 over the last 52 weeks.
According to 36 analysts, the price of SUNPHARMA in the future is projected to be between 1575.0 and 2392.0, with an average expected price of 1958.9166.

Technicals

Support and Resistance: At 1808.3, the price is held up by support at 1777.4 and faces resistance at 1818.3 for SUNPHARMA. This suggests a trading range where 1777.4 provides a base and 1818.3 limits upward movement.
SUNPHARMA supportResistance cefdae
Support/Resistance for SUNPHARMA


Aroon: Aroon's bullish trend remains intact, with Aroon Up at the 100 level. This indicates strong market momentum, but a more comprehensive analysis using other indicators is required to assess the trend's strength and potential for continuation.
SUNPHARMA aroon cefdae
Aroon chart for Sun Pharmaceutical Industries Limited


Bol. Bands: The latest price action has seen the current price cross above the upper Bollinger Band, signaling a bullish trend. This upward break suggests that the market is experiencing strong buying pressure, pushing prices higher. Such a move is often seen as an indicator of increasing momentum, potentially leading to further gains for SUNPHARMA.
SUNPHARMA bbands cefdae
Bolinger Bands chart for Sun Pharmaceutical Industries Limited


Parabolic SAR: The PSAR continues to be bullish for SUNPHARMA, setting a strong support level that could sustain the ongoing upward trend. This level of support indicates that the market is likely to continue its positive trajectory, offering a base for continued bullish movement.
SUNPHARMA psar cefdae
Parabolic Stop and Reverse chart for Sun Pharmaceutical Industries Limited


Stochastic: The stochastic indicator is in a bullish position, with the K-line above both the D-line and the 80 level. This configuration suggests strong upward momentum, indicating that the market may continue its positive trend. Traders might view this as a sign of ongoing strength in the market.
SUNPHARMA stoch cefdae
Stochastic chart for Sun Pharmaceutical Industries Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral for SUNPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
SUNPHARMA trippleSMA cefdae
Tripple SMA chart for Sun Pharmaceutical Industries Limited


To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.